Alejandra Romero-Utrilla

Dr. Alejandra Romero-Utrilla


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JOJuan Fidel Osuna-Ramos
Juan Fidel Osuna-Ramos
José Manuel Reyes-RuizJosé Manuel Reyes-Ruiz
José Manuel Reyes-Ruiz
LOLuis Antonio Ochoa-Ramirez
Luis Antonio Ochoa-Ramirez
Luis Adrián De Jesús GonzálezLuis Adrián De Jesús González
Luis Adrián De Jesús González
RRRosalio Ramos-Payan
Rosalio Ramos-Payan
JVJesús Salvador Velarde-Félix
Jesús Salvador Velarde-Félix
COVID-19 and dengue disease are challenging to tell apart because they have similarities in clinical and laboratory features during the acute phase of infection, leading to misdiagnosis and delayed treatment. The present study evaluated peripheral blood cell count accuracy to distinguish COVID-19 non-critical patients from non-severe dengue cases between the second and eleventh day after symptom onset. A total of 288 patients infected with SARS-CoV-2 (n = 105) or dengue virus (n = 183) were included in this study. Neutrophil, platelet, and lymphocyte counts were used to calculate the neutrophil–lymphocyte ratio (NLR), the platelet–lymphocyte ratio (PLR), and the neutrophil–lymphocyte*platelet ratio (NLPR). The logistic regression and ROC curves analysis revealed that neutrophil and platelet counts, NLR, LPR, and NLPR were higher in COVID-19 than dengue. The multivariate predictive model showed that the neutrophils, platelets, and NLPR were independently associated with COVID-19 with a good fit predictive value (p = 0.1041). The neutrophil (AUC = 0.95, 95% CI = 0.84–0.91), platelet (AUC = 0.89, 95% CI = 0.85–0.93) counts, and NLR (AUC = 0.88, 95% CI = 0.84–0.91) were able to discriminate COVID-19 from dengue with high sensitivity and specificity values (above 80%). Finally, based on predicted probabilities on combining neutrophils and platelets with NLR or NLPR, the adjusted AUC was 0.97 (95% CI = 0.94–0.98) to differentiate COVID-19 from dengue during the acute phase of infection with outstanding accuracy. These findings might suggest that the neutrophil, platelet counts, and NLR or NLPR provide a quick and cost-effective way to distinguish between dengue and COVID-19 in the context of co-epidemics in low-income tropical regions.

14 August 2024 in Marine Drugs
Verified
Journal Article
Open access
PDF file
BSBianca Vianey Rivera Serrano
Bianca Vianey Rivera Serrano
SCSandy Lucero Cabanillas-Salcido
Sandy Lucero Cabanillas-Salcido
CRCarlos Daniel Cordero Rivera
Carlos Daniel Cordero Rivera
RCRicardo Jiménez Camacho
Ricardo Jiménez Camacho
CNClaudia Desireé Norzagaray-Valenzuela
Claudia Desireé Norzagaray-Valenzuela
JOJuan Fidel Osuna-Ramos
Juan Fidel Osuna-Ramos
Dengue, caused by the dengue virus (DENV), is a global health threat transmitted by Aedes mosquitoes, resulting in 400 million cases annually. The disease ranges from mild to severe, with potential progression to hemorrhagic dengue. Current research is focused on natural antivirals due to challenges in vector control. This study evaluates the antiviral potential of peptides derived from the microalgae Phaeodactylum tricornutum, known for its bioactive compounds. Microalgae were cultivated under controlled conditions, followed by protein extraction and hydrolysis to produce four peptide fractions. These fractions were assessed for cytotoxicity via the MTT assay and antiviral activity against DENV serotype 2 using flow cytometry and plaque formation assays. The 10–30 kDa peptide fraction, at 150 and 300 μg/mL concentrations, demonstrated no cytotoxicity and significantly reduced the percentage of infected cells and viral titers. These findings suggest that peptides derived from Phaeodactylum tricornutum exhibit promising antiviral activity against dengue virus serotype 2, potentially contributing to developing new therapeutic approaches for dengue.

11 September 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
Alberto Kousuke De la Herrán-AritaAlberto Kousuke De la Herrán-Arita
Alberto Kousuke De la Herrán-Arita
CGCuitláhuac González-Galindo
Cuitláhuac González-Galindo
GIGerardo Kenny Inzunza-Leyva
Gerardo Kenny Inzunza-Leyva
MVMarco Antonio Valdez-Flores
Marco Antonio Valdez-Flores
CNClaudia Desireé Norzagaray-Valenzuela
Claudia Desireé Norzagaray-Valenzuela
JOJuan Fidel Osuna-Ramos
Juan Fidel Osuna-Ramos
Monkeypox (Mpox) is an emerging zoonotic disease with the potential for severe complications. Early identification and diagnosis are essential to prompt treatment, control its spread, and reduce the risk of human-to-human transmission. This study aimed to develop a clinical diagnostic tool and describe the clinical and sociodemographic features of 19 PCR-confirmed Mpox cases during an outbreak in a nonendemic region of northwestern Mexico. The median age of patients was 35 years, and most were male. Mpox-positive patients commonly reported symptoms such as fever, lumbago, and asthenia, in addition to experiencing painful ulcers and a high frequency of HIV infection among people living with HIV (PLWH). Two diagnostic models using logistic regression were devised, with the best model exhibiting a prediction accuracy of 0.92 (95% CI: 0.8–1), a sensitivity of 0.86, and a specificity of 0.93. The high predictive values and accuracy of the top-performing model highlight its potential to significantly improve early Mpox diagnosis and treatment in clinical settings, aiding in the control of future outbreaks.

26 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
JOJuan Fidel Osuna-Ramos
Juan Fidel Osuna-Ramos
HRHoracio Rendón-Aguilar
Horacio Rendón-Aguilar
Luis Adrián De Jesús GonzálezLuis Adrián De Jesús González
Luis Adrián De Jesús González
José Manuel Reyes-RuizJosé Manuel Reyes-Ruiz
José Manuel Reyes-Ruiz
AEArely Montserrat Espinoza-Ortega
Arely Montserrat Espinoza-Ortega
JVJesús Salvador Velarde-Félix
Jesús Salvador Velarde-Félix
Background: COVID-19 has been recognized as an emerging and rapidly evolving health condition. For this reason, efforts to determine changes in laboratory parameters of COVID-19 patients as biomarkers are urgent. Lipids are essential components of the human body, and their modulation has been observed implicated in some viral infections. Methods: To evaluate the clinical diagnosis utility of the lipid profile changes in Mexican COVID-19 patients, the lipid profile of one hundred two COVID-19 positive patients from three hospitals in Culiacan, Sinaloa in northwest Mexico, was analyzed. ROC curves and binary logistic regression analysis were used as a predictive model to determine their clinical diagnostic utility. Results: Significant changes in the serum lipid profile of patients with COVID-19, such as low levels of cholesterol, LDL, and HDL, while high triglycerides and VLDL were observed. The same abnormalities in the lipid profile among non-critical and critical COVID-19 patients were detected. The predictive model analysis suggests that cholesterol and LDL have AUC values of 0.710 and 0.769, respectively, for COVID-19 (p= 0.0002 and p= <0.0001), and LDL low levels might be a risk factor for critical COVID-19 (OR= 2.07, 95% IC: 1.18 to 3.63; p= 0.01). Conclusion: Our findings suggest that low cholesterol and LDL levels could be considered an acceptable predictor for COVID-19, and low levels of LDL might be a risk factor for critical COVID-19 patients.

8 August 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
SMSaulo Mendoza-Ramirez
Saulo Mendoza-Ramirez
CHClaudia Mariana Hernández-Robles
Claudia Mariana Hernández-Robles
IVItalú Velasco-Rueda
Italú Velasco-Rueda
ARAlejandra Romero-Utrilla
Alejandra Romero-Utrilla
MZMyrna Doris Arrecillas Zamora
Myrna Doris Arrecillas Zamora
Mario Murguia-PerezMario Murguia-Perez
Mario Murguia-Perez
Myxoid endometriosis is a rare entity that is part of the histological changes that can occur in endometriosis. It is extremely important that the pathologist has knowledge of the histological guidelines for the morphological recognition of this entity, as well as the histochemical and immunohistochemical techniques that will support the diagnosis. Define the morphological characteristics of myxoid endometriosis. In the present work we propose diagnostic approach guidelines, as well as the main differential diagnoses with the use of special histochemical techniques and immunohistochemical reactions to recognize this entity.

11 October 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
SMSaulo Mendoza-Ramirez
Saulo Mendoza-Ramirez
CHClaudia Mariana Hernández-Robles
Claudia Mariana Hernández-Robles
IVItalú Velasco-Rueda
Italú Velasco-Rueda
ARAlejandra Romero-Utrilla
Alejandra Romero-Utrilla
MZMyrna Doris Arrecillas Zamora
Myrna Doris Arrecillas Zamora
Mario Murguia-PerezMario Murguia-Perez
Mario Murguia-Perez
Myxoid endometriosis, a rare entity, is part of the histological changes that can occur in endometriosis. Pathologists must know the histological guidelines for the morphological recognition of this entity, as well as the histochemical and immunohistochemical techniques that support diagnosis, and define the morphological characteristics of myxoid endometriosis. In the present work, we propose diagnostic guidelines and primary differential diagnoses using special histochemical techniques and immunohistochemical reactions to recognize this entity.